Share Price and Basic Stock Data
Last Updated: February 7, 2026, 8:12 pm
| PEG Ratio | -2.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Uniphos Enterprises Ltd, with a market capitalization of ₹740 Cr, operates in an undefined industry sector. The company’s stock price stood at ₹106, with a P/E ratio of 39.0. Over the years, Uniphos has experienced significant fluctuations in revenue. Sales reported for FY 2023 were a mere ₹1 Cr, a stark contrast to the FY 2025 estimate of ₹112 Cr. This increase in revenue showcases a potential recovery trajectory, with quarterly sales in FY 2024 indicating a gradual rise, peaking at ₹51 Cr in Mar 2024 before tapering to ₹73 Cr in Mar 2025. However, the company faced challenges in the interim, with zero sales reported in multiple quarters, including Jun 2023 and Sep 2023. The inconsistency in revenue generation raises concerns about the sustainability of operations and market demand for its products. Overall, while there are signs of recovery, the historical volatility in revenue requires careful scrutiny moving forward.
Profitability and Efficiency Metrics
Profitability metrics for Uniphos Enterprises Ltd reveal a challenging landscape. The company reported a net profit of ₹19 Cr, equating to a meager return on equity (ROE) of 0.01% and a return on capital employed (ROCE) of 0.06%. The operating profit margin (OPM) has shown an alarming trend, with OPM standing at -3% in FY 2025, highlighting persistent inefficiencies in cost management. Operating losses were recorded in several quarters, with the most recent reports indicating a consistent negative operating profit from Sep 2022 through to Jun 2025. Additionally, the interest coverage ratio (ICR) of 1.75x indicates a precarious situation for meeting interest obligations, although the absence of significant borrowings (₹1 Cr) mitigates immediate financial distress. Overall, the lack of profitability and operational efficiency raises significant concerns about Uniphos’ ability to sustain its business operations in the long term.
Balance Sheet Strength and Financial Ratios
Uniphos Enterprises Ltd’s balance sheet reflects a substantial reserve position of ₹2,831 Cr, which provides a cushion against operational challenges. The company’s borrowings remain negligible at ₹1 Cr, indicating a low debt burden, which is favorable for financial stability. However, the price-to-book value ratio (P/BV) of 0.41x suggests that the market may undervalue the company relative to its book value, which stood at ₹394.22 per share as of Mar 2025. The current ratio of 8.83x indicates strong liquidity, far exceeding typical sector benchmarks, thus allowing the company to cover its short-term liabilities comfortably. Despite these strengths, the return on assets (ROA) at 0.00% signals ineffective asset utilization. Furthermore, financial ratios such as the enterprise value to EBITDA ratio of 464.68x indicate that the company may be overvalued compared to its earnings potential, suggesting a disconnect between market perception and financial reality.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Uniphos Enterprises Ltd reflects a stable ownership structure, with promoters holding 73.79% as of Sep 2025. This substantial promoter stake provides a strong indication of confidence in the company’s long-term strategy. Foreign institutional investors (FIIs) accounted for 15.71% of the holdings, demonstrating a moderate level of external interest. However, the absence of domestic institutional investors (DIIs) may reflect a lack of confidence among local institutions in the company’s performance. The total number of shareholders stood at 12,699, indicating a relatively broad base of retail investors, which can be seen as a positive sign for liquidity. Nonetheless, the declining trend in net profit and the significant dividend payout ratio of 14,244.01% raises concerns about sustainability in returns for shareholders, potentially affecting investor sentiment and confidence moving forward.
Outlook, Risks, and Final Insight
The outlook for Uniphos Enterprises Ltd appears mixed, with potential for revenue recovery juxtaposed against significant profitability challenges. The projected sales growth in FY 2025 could signify an upward trend, yet the persistent operational losses and inefficiencies must be addressed for sustainable growth. Key risks include the company’s historical volatility in revenue generation, low profitability margins, and ineffective asset utilization, which could impact future performance. Furthermore, the high dividend payout ratio raises concerns about the sustainability of returns, potentially leading to liquidity issues if cash flows do not improve. In scenarios where operational efficiencies are improved and revenue stabilizes, Uniphos could see a resurgence in investor confidence. Conversely, failure to address these operational challenges could result in further declines in profitability and market valuation, necessitating a vigilant approach from stakeholders.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 113 Cr. | 29.4 | 749/20.5 | 1.10 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 3,066 Cr. | 190 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 38.5 Cr. | 3.02 | 7.43/2.70 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,203.29 Cr | 210.89 | 313.19 | 219.29 | 0.26% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 0 | 0 | 0 | 0 | 0 | 51 | 3 | 30 | 5 | 73 | 6 | 0 |
| Expenses | 2 | 1 | 1 | 1 | 1 | 1 | 52 | 4 | 31 | 6 | 74 | 7 | 1 |
| Operating Profit | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -0 | -1 | -2 | -1 | -1 |
| OPM % | -53% | -2% | -25% | -2% | -20% | -2% | -14% | ||||||
| Other Income | 40 | 1 | 1 | 1 | 40 | 1 | 1 | 1 | 5 | 0 | 0 | 0 | 24 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 39 | -0 | 0 | -0 | 39 | -0 | -0 | -0 | 4 | -2 | -2 | -1 | 23 |
| Tax % | 0% | 1,017% | -135% | 0% | 0% | 0% | 50% | 0% | 0% | -3% | 0% | 0% | 0% |
| Net Profit | 39 | -1 | 0 | -0 | 39 | -0 | -1 | -0 | 4 | -2 | -2 | -1 | 23 |
| EPS in Rs | 5.65 | -0.10 | 0.07 | -0.01 | 5.66 | -0.00 | -0.09 | -0.02 | 0.56 | -0.27 | -0.23 | -0.11 | 3.33 |
Last Updated: February 3, 2026, 6:16 pm
Below is a detailed analysis of the quarterly data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 6.00 Cr..
- For Expenses, as of Sep 2025, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 7.00 Cr. (Jun 2025) to 1.00 Cr., marking a decrease of 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded -1.00 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value appears strong and on an upward trend. It has increased from -14.00% (Jun 2025) to 0.00%, marking an increase of 14.00%.
- For Other Income, as of Sep 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 24.00 Cr., marking an increase of 24.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 24.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 23.00 Cr.. The value appears strong and on an upward trend. It has increased from -1.00 Cr. (Jun 2025) to 23.00 Cr., marking an increase of 24.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 3.33. The value appears strong and on an upward trend. It has increased from -0.11 (Jun 2025) to 3.33, marking an increase of 3.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 51 | 112 | 84 |
| Expenses | 10 | 3 | 1 | 2 | 2 | 3 | 2 | 4 | 4 | 4 | 54 | 115 | 88 |
| Operating Profit | -1 | -1 | -1 | -2 | -2 | -3 | -2 | -3 | -3 | -3 | -3 | -4 | -5 |
| OPM % | -6% | -47% | -987% | -370% | -257% | -195% | -6% | -3% | -5% | ||||
| Other Income | 7 | 11 | 14 | 13 | 20 | 24 | 23 | 26 | 57 | 43 | 43 | 6 | 25 |
| Interest | 8 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 23 | 54 | 40 | 39 | 0 | 19 |
| Tax % | 0% | 0% | 0% | 0% | 2% | 2% | 2% | -4% | -1% | 1% | 1% | -22% | |
| Net Profit | -2 | 9 | 12 | 11 | 18 | 21 | 20 | 24 | 55 | 39 | 39 | 0 | 19 |
| EPS in Rs | -0.23 | 1.23 | 1.70 | 1.62 | 2.54 | 2.99 | 2.89 | 3.52 | 7.85 | 5.64 | 5.55 | 0.04 | 2.72 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 97% | 72% | 115% | 103% | 1,242% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 550.00% | 33.33% | -8.33% | 63.64% | 16.67% | -4.76% | 20.00% | 129.17% | -29.09% | 0.00% | -100.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -516.67% | -41.67% | 71.97% | -46.97% | -21.43% | 24.76% | 109.17% | -158.26% | 29.09% | -100.00% |
Uniphos Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 50% |
| 5 Years: | 244% |
| 3 Years: | 350% |
| TTM: | 113% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -29% |
| 5 Years: | -58% |
| 3 Years: | -83% |
| TTM: | -101% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 18% |
| 3 Years: | 5% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 0% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: January 7, 2026, 4:35 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
| Reserves | 249 | 258 | 270 | 2,053 | 2,076 | 2,684 | 1,504 | 2,701 | 3,167 | 2,984 | 2,062 | 2,728 | 2,831 |
| Borrowings | 10 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Other Liabilities | 7 | 0 | 0 | 0 | 0 | 0 | 1 | 57 | 121 | 98 | 2 | 100 | 117 |
| Total Liabilities | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
| Fixed Assets | 174 | 174 | 174 | 175 | 175 | 175 | 175 | 176 | 176 | 184 | 183 | 182 | 182 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 84 | 84 | 84 | 1,856 | 1,871 | 2,483 | 1,261 | 2,550 | 3,080 | 2,856 | 1,802 | 2,616 | 2,735 |
| Other Assets | 23 | 24 | 26 | 36 | 44 | 40 | 83 | 46 | 46 | 55 | 92 | 44 | 46 |
| Total Assets | 281 | 282 | 284 | 2,067 | 2,090 | 2,698 | 1,519 | 2,772 | 3,302 | 3,095 | 2,078 | 2,842 | 2,962 |
Below is a detailed analysis of the balance sheet data for Uniphos Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 14.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,831.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,728.00 Cr. (Mar 2025) to 2,831.00 Cr., marking an increase of 103.00 Cr..
- For Borrowings, as of Sep 2025, the value is 1.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.00 Cr. (Mar 2025) to 1.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 117.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 100.00 Cr. (Mar 2025) to 117.00 Cr., marking an increase of 17.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,962.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 182.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 182.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2,735.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,616.00 Cr. (Mar 2025) to 2,735.00 Cr., marking an increase of 119.00 Cr..
- For Other Assets, as of Sep 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 2.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,962.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,842.00 Cr. (Mar 2025) to 2,962.00 Cr., marking an increase of 120.00 Cr..
Notably, the Reserves (2,831.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -11.00 | -11.00 | -1.00 | -2.00 | -2.00 | -3.00 | -2.00 | -3.00 | -3.00 | -3.00 | -3.00 | -4.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Inventory Days | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | -0 | -0 | -0 | -0 | -0 | -0 | 3 | -0 | ||||
| Working Capital Days | -692 | -1,982 | 24,772 | 6,680 | 4,434 | 17 | -11 | -6 | ||||
| ROCE % | 2% | 3% | 4% | 1% | 1% | 1% | 1% | 1% | 2% | 1% | 1% | 0% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Diluted EPS (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| Cash EPS (Rs.) | 0.14 | 5.67 | 5.73 | 7.86 | 3.52 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 373.37 | 277.58 | 410.17 | 436.48 | 369.50 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 394.22 | 298.43 | 431.02 | 457.33 | 390.35 |
| Dividend / Share (Rs.) | 0.50 | 5.70 | 6.50 | 5.65 | 3.40 |
| Revenue From Operations / Share (Rs.) | 16.03 | 7.28 | 0.21 | 0.17 | 0.11 |
| PBDIT / Share (Rs.) | 0.33 | 5.72 | 5.78 | 7.76 | 3.37 |
| PBIT / Share (Rs.) | 0.22 | 5.60 | 5.70 | 7.76 | 3.36 |
| PBT / Share (Rs.) | 0.03 | 5.60 | 5.70 | 7.76 | 3.36 |
| Net Profit / Share (Rs.) | 0.04 | 5.55 | 5.64 | 7.85 | 3.52 |
| PBDIT Margin (%) | 2.06 | 78.53 | 2732.78 | 4417.35 | 2813.99 |
| PBIT Margin (%) | 1.38 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| PBT Margin (%) | 0.20 | 76.89 | 2691.84 | 4414.67 | 2809.84 |
| Net Profit Margin (%) | 0.24 | 76.24 | 2664.95 | 4469.11 | 2936.36 |
| Return on Networth / Equity (%) | 0.01 | 2.00 | 1.37 | 1.79 | 0.95 |
| Return on Capital Employeed (%) | 0.05 | 1.87 | 1.28 | 1.63 | 0.84 |
| Return On Assets (%) | 0.00 | 1.85 | 1.26 | 1.65 | 0.88 |
| Asset Turnover Ratio (%) | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 |
| Current Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Quick Ratio (X) | 8.83 | 23.44 | 50.39 | 100.10 | 229.58 |
| Dividend Payout Ratio (NP) (%) | 14244.01 | 117.06 | 100.17 | 43.30 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 3837.47 | 114.59 | 98.65 | 43.27 | 0.00 |
| Earning Retention Ratio (%) | -14144.01 | -17.06 | -0.17 | 56.70 | 0.00 |
| Cash Earning Retention Ratio (%) | -3737.47 | -14.59 | 1.35 | 56.73 | 0.00 |
| Interest Coverage Ratio (X) | 1.75 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (X) | 1.21 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value (Cr.) | 1068.15 | 884.06 | 1038.32 | 913.70 | 586.13 |
| EV / Net Operating Revenue (X) | 9.58 | 17.46 | 705.43 | 747.83 | 703.89 |
| EV / EBITDA (X) | 464.68 | 22.23 | 25.81 | 16.93 | 25.01 |
| MarketCap / Net Operating Revenue (X) | 9.72 | 18.39 | 727.16 | 753.35 | 709.07 |
| Retention Ratios (%) | -14144.01 | -17.06 | -0.17 | 56.69 | 0.00 |
| Price / BV (X) | 0.41 | 0.48 | 0.37 | 0.30 | 0.22 |
| Price / Net Operating Revenue (X) | 9.72 | 18.39 | 727.32 | 753.70 | 709.87 |
| EarningsYield | 0.00 | 0.04 | 0.03 | 0.05 | 0.04 |
After reviewing the key financial ratios for Uniphos Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.14. This value is below the healthy minimum of 3. It has decreased from 5.67 (Mar 24) to 0.14, marking a decrease of 5.53.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 373.37. It has increased from 277.58 (Mar 24) to 373.37, marking an increase of 95.79.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 394.22. It has increased from 298.43 (Mar 24) to 394.22, marking an increase of 95.79.
- For Dividend / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 5.70 (Mar 24) to 0.50, marking a decrease of 5.20.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 16.03. It has increased from 7.28 (Mar 24) to 16.03, marking an increase of 8.75.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 2. It has decreased from 5.72 (Mar 24) to 0.33, marking a decrease of 5.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.22. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.22, marking a decrease of 5.38.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 5.60 (Mar 24) to 0.03, marking a decrease of 5.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 2. It has decreased from 5.55 (Mar 24) to 0.04, marking a decrease of 5.51.
- For PBDIT Margin (%), as of Mar 25, the value is 2.06. This value is below the healthy minimum of 10. It has decreased from 78.53 (Mar 24) to 2.06, marking a decrease of 76.47.
- For PBIT Margin (%), as of Mar 25, the value is 1.38. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 1.38, marking a decrease of 75.51.
- For PBT Margin (%), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 10. It has decreased from 76.89 (Mar 24) to 0.20, marking a decrease of 76.69.
- For Net Profit Margin (%), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 76.24 (Mar 24) to 0.24, marking a decrease of 76.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 15. It has decreased from 2.00 (Mar 24) to 0.01, marking a decrease of 1.99.
- For Return on Capital Employeed (%), as of Mar 25, the value is 0.05. This value is below the healthy minimum of 10. It has decreased from 1.87 (Mar 24) to 0.05, marking a decrease of 1.82.
- For Return On Assets (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 1.85 (Mar 24) to 0.00, marking a decrease of 1.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.04. It has increased from 0.01 (Mar 24) to 0.04, marking an increase of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 3. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Quick Ratio (X), as of Mar 25, the value is 8.83. This value exceeds the healthy maximum of 2. It has decreased from 23.44 (Mar 24) to 8.83, marking a decrease of 14.61.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14,244.01. This value exceeds the healthy maximum of 50. It has increased from 117.06 (Mar 24) to 14,244.01, marking an increase of 14,126.95.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 3,837.47. This value exceeds the healthy maximum of 50. It has increased from 114.59 (Mar 24) to 3,837.47, marking an increase of 3,722.88.
- For Earning Retention Ratio (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 40. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is -3,737.47. This value is below the healthy minimum of 40. It has decreased from -14.59 (Mar 24) to -3,737.47, marking a decrease of 3,722.88.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.75. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.75, marking an increase of 1.75.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 3. It has increased from 0.00 (Mar 24) to 1.21, marking an increase of 1.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,068.15. It has increased from 884.06 (Mar 24) to 1,068.15, marking an increase of 184.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 9.58. This value exceeds the healthy maximum of 3. It has decreased from 17.46 (Mar 24) to 9.58, marking a decrease of 7.88.
- For EV / EBITDA (X), as of Mar 25, the value is 464.68. This value exceeds the healthy maximum of 15. It has increased from 22.23 (Mar 24) to 464.68, marking an increase of 442.45.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For Retention Ratios (%), as of Mar 25, the value is -14,144.01. This value is below the healthy minimum of 30. It has decreased from -17.06 (Mar 24) to -14,144.01, marking a decrease of 14,126.95.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.48 (Mar 24) to 0.41, marking a decrease of 0.07.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 9.72. This value exceeds the healthy maximum of 3. It has decreased from 18.39 (Mar 24) to 9.72, marking a decrease of 8.67.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Uniphos Enterprises Ltd:
- Net Profit Margin: 0.24%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 0.05% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0.01% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.21
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.83
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42.1 (Industry average Stock P/E: 313.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.24%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | 11, G.I.D.C., Vapi, Valsad District Gujarat 396195 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Arun Chandrasen Ashar | Chairman & Non-Exe.Director |
| Mrs. Sandra Rajnikant Shroff | Managing Director |
| Mrs. Meena Deepak Ved | Independent Director |
| Mr. Jaidev Rajnikant Shroff | Non Executive Director |
| Mr. Prasad Vasudev Paranjape | Independent Director |
| Mr. Suresh Balasubramaniam | Independent Director |
FAQ
What is the intrinsic value of Uniphos Enterprises Ltd?
Uniphos Enterprises Ltd's intrinsic value (as of 08 February 2026) is ₹1.12 which is 99.07% lower the current market price of ₹120.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹835 Cr. market cap, FY2025-2026 high/low of ₹173/100, reserves of ₹2,831 Cr, and liabilities of ₹2,962 Cr.
What is the Market Cap of Uniphos Enterprises Ltd?
The Market Cap of Uniphos Enterprises Ltd is 835 Cr..
What is the current Stock Price of Uniphos Enterprises Ltd as on 08 February 2026?
The current stock price of Uniphos Enterprises Ltd as on 08 February 2026 is ₹120.
What is the High / Low of Uniphos Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Uniphos Enterprises Ltd stocks is ₹173/100.
What is the Stock P/E of Uniphos Enterprises Ltd?
The Stock P/E of Uniphos Enterprises Ltd is 42.1.
What is the Book Value of Uniphos Enterprises Ltd?
The Book Value of Uniphos Enterprises Ltd is 409.
What is the Dividend Yield of Uniphos Enterprises Ltd?
The Dividend Yield of Uniphos Enterprises Ltd is 0.42 %.
What is the ROCE of Uniphos Enterprises Ltd?
The ROCE of Uniphos Enterprises Ltd is 0.06 %.
What is the ROE of Uniphos Enterprises Ltd?
The ROE of Uniphos Enterprises Ltd is 0.01 %.
What is the Face Value of Uniphos Enterprises Ltd?
The Face Value of Uniphos Enterprises Ltd is 2.00.